Učitavanje...
Tailoring combinatorial cancer therapies to target the origins of adaptive resistance
The development of resistance to chemotherapy is a critical yet poorly understood phenomenon driving cancer-related deaths. We recently reported a study that explored the origins of adaptive chemotherapy resistance. During this investigation we unexpectedly discovered that inherent vulnerabilities w...
Spremljeno u:
| Izdano u: | Mol Cell Oncol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845182/ https://ncbi.nlm.nih.gov/pubmed/27308546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1030534 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|